Orexin Restoration in Narcolepsy: Breakthroughs in Cellular Therapy
Journal of Sleep Research · 2026
DOI: 10.1111/jsr.70083 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Sleep Research, 2026. Verfasst von Emmanuel Ortega-Robles und 6 weiteren Autor:innen. Beteiligte Einrichtung: Unidad de Trastornos del Movimiento y Sueño (TMS), Hospital General Dr. Manuel Gea González, Ciudad de México, Mexico. Hauptthemen laut MEDLINE: Orexins, Narcolepsy, Cell Transplantation, Cell- and Tissue-Based Therapy. Die Arbeit nennt 234 Literaturangaben.
Abstract (Originalsprache)
Narcolepsy is a chronic neurodegenerative disorder defined by the selective loss of orexin‐producing neurons in the lateral hypothalamus, leading to excessive daytime sleepiness and cataplexy. While pharmacological therapies have evolved to mitigate symptoms, they fail to address the core pathology—orexin deficiency. This narrative review examines the potential of orexin cell transplantation as an innovative therapeutic approach to restore orexin signalling and treat the root cause of narcolepsy. We begin by examining the clinical features, pathophysiology, and diagnostic criteria of narcolepsy, focusing on the essential role of orexins in regulating the sleep–wake cycle and the neurobiological mechanisms underlying cataplexy. The review then explores experimental therapeutic approaches, including hypothalamic tissue grafts, gene therapy, and immortalised orexin‐expressing cell lines, highlighting their potential to address the orexin deficit in narcolepsy. While preclinical studies show that transplanted orexin cells can integrate into host neural networks, enhance sleep stability, and decrease the frequency of cataplexy in animal models, several challenges remain. Immortalised orexin cell lines offer a scalable and consistent option for transplantation therapies. However, immune rejection, long‐term cell survival, and complete functional integration persist. These translational hurdles must be addressed to bring these therapies to clinical practice. This review underscores the need for continued research to overcome these barriers and optimise cell‐based therapies for narcolepsy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Unidad de Trastornos del Movimiento y Sueño (TMS), Hospital General Dr. Manuel Gea González, Ciudad de México, Mexico.
- Departamento de Fisiología, Facultad de Medicina, Laboratorio de Medicina Regenerativa y Canales Iónicos, Universidad Nacional Autónoma de México, Ciudad de México, Mexico.
- Institute of Global Health and Human Ecology, School of Sciences & Engineering, The American University in Cairo, New Cairo, Egypt.
- Programa de Doctorado en Ciencias Biomédicas, Universidad Nacional Autónoma de México, Ciudad de México, Mexico.
- Department of Histology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Katowice, Poland.
- Experimental Neurology, Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra, Mexico City, Mexico.
ORCID-Profile: Oscar Arias-Carrión
Zitieren
APA
Ortega-Robles, E., Guerra-Crespo, M., Ezzeldin, S., Santana-Román, E., Pałasz, A., Salama, M., & Arias-Carrión, O. (2026). Orexin Restoration in Narcolepsy: Breakthroughs in Cellular Therapy. Journal of Sleep Research. https://doi.org/10.1111/jsr.70083
Vancouver
Ortega-Robles E, Guerra-Crespo M, Ezzeldin S, Santana-Román E, Pałasz A, Salama M, et al. Orexin Restoration in Narcolepsy: Breakthroughs in Cellular Therapy. Journal of Sleep Research. 2026. doi:10.1111/jsr.70083
BibTeX
@article{OrtegaRobles2026,
author = {Ortega-Robles, Emmanuel and Guerra-Crespo, Magdalena and Ezzeldin, Shahd and Santana-Román, Estefanía and Pałasz, Artur and Salama, Mohamed and Arias-Carrión, Oscar},
title = {Orexin Restoration in Narcolepsy: Breakthroughs in Cellular Therapy},
journal = {Journal of Sleep Research},
year = {2026},
doi = {10.1111/jsr.70083}
}
EUVIMED